Stay updated on Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a consolidated Locations section listing Florida, Iowa, Minnesota, Nebraska, Oregon, and Pennsylvania. Updated the revision to v3.3.3 and removed the prior separate location sections (Florida Locations, Iowa Locations, Minnesota Locations, Nebraska Locations, Oregon Locations, Pennsylvania Locations) along with the HHS Vulnerability Disclosure link.SummaryDifference0.7%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.3.1 has been removed.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded revision v3.3.1 and removed revision v3.2.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe notice about government funding and potential updates to the NIH/CC operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedNo substantive additions or deletions were observed in the Study Details page for NCT03241186; the content and layout appear unchanged. The page continues to present trial design, eligibility, outcomes, and contacts as before.SummaryDifference0.4%

- Check93 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference3%

Stay in the know with updates to Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.